TEM8 Antibodies

Santa Cruz Biotechnology provides a broad selection of TEM8 Antibodies for advanced research in cell biology and cancer studies. TEM8 Antibodies targeting TEM8 are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TEM8, or Tumor Endothelial Marker 8, plays a crucial role in angiogenesis and is primarily expressed in the endothelial cells of tumors. The involvement of TEM8 in tumor growth and metastasis makes it a significant target for cancer research and therapeutic development. Understanding TEM8 function provides valuable insights into tumor biology and potential treatment strategies. Researchers worldwide utilize TEM8 monoclonal antibodies to explore cellular mechanisms and pathways involved in cancer progression. Advanced detection methods, including fluorescent conjugates such as phycoerythrin (PE), fluorescein isothiocyanate (FITC), and horseradish peroxidase (HRP), enable precise visualization of TEM8 expression patterns. Santa Cruz Biotechnology monoclonal antibodies targeting TEM8 continue to support breakthrough discoveries in cancer research and therapeutic development.